Mainstay Medical Published Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study
On November 22, 2022, Mainstay Medical, a medical devices company, announced that the data from the ReActiv8®-C study, a single-centre, real-world study with a one-year clinical follow-up of selected patients, is published.
ReActiv8 is an implantable medical device designed to treat adults suffering from chronic low back pain (CLBP) caused by multifidus muscle dysfunction. Imaging or physiological testing may reveal multifidus muscle dysfunction in adults who have failed therapy, including pain medications and physical therapy and are not candidates for spine su...
